|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0006141,
umls-concept:C0006142,
umls-concept:C0015737,
umls-concept:C0021149,
umls-concept:C0021853,
umls-concept:C0026882,
umls-concept:C0039286,
umls-concept:C0043210,
umls-concept:C0376571,
umls-concept:C0439660,
umls-concept:C0543467,
umls-concept:C0598034,
umls-concept:C1511293,
umls-concept:C1522673,
umls-concept:C1709701
|
|
pubmed:issue |
18
|
|
pubmed:dateCreated |
2001-11-16
|
|
pubmed:abstractText |
Among cancer-free women aged 35 years or older, tamoxifen reduced the incidence of estrogen receptor (ER)-positive but not ER-negative breast cancer. The effect of tamoxifen on breast cancer incidence among women at extremely high risk due to inherited BRCA1 or BRCA2 mutations is unknown.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0098-7484
|
|
pubmed:author |
pubmed-author:CostantinoJJ,
pubmed-author:FisherBB,
pubmed-author:FordLL,
pubmed-author:GINOR MRM,
pubmed-author:HaleKK,
pubmed-author:LANED GDG,
pubmed-author:LeaII,
pubmed-author:National Surgical Adjuvant Breast and Bowel Project,
pubmed-author:OwensKK,
pubmed-author:TaitJJ,
pubmed-author:WalshTT,
pubmed-author:WickerhamLL,
pubmed-author:WieandSS,
pubmed-author:WolmarkNN
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
14
|
|
pubmed:volume |
286
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2251-6
|
|
pubmed:dateRevised |
2007-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:11710890-Adult,
pubmed-meshheading:11710890-Aged,
pubmed-meshheading:11710890-Antineoplastic Agents, Hormonal,
pubmed-meshheading:11710890-Breast Neoplasms,
pubmed-meshheading:11710890-DNA Mutational Analysis,
pubmed-meshheading:11710890-Double-Blind Method,
pubmed-meshheading:11710890-Female,
pubmed-meshheading:11710890-Genes, BRCA1,
pubmed-meshheading:11710890-Genes, BRCA2,
pubmed-meshheading:11710890-Genetic Predisposition to Disease,
pubmed-meshheading:11710890-Humans,
pubmed-meshheading:11710890-Incidence,
pubmed-meshheading:11710890-Middle Aged,
pubmed-meshheading:11710890-Mutation,
pubmed-meshheading:11710890-Receptors, Estrogen,
pubmed-meshheading:11710890-Risk Factors,
pubmed-meshheading:11710890-Tamoxifen
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial.
|
|
pubmed:affiliation |
University of Washington, Seattle, WA 98195, USA. mcking@u.washington.edu
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, U.S. Gov't, P.H.S.,
Randomized Controlled Trial,
Multicenter Study
|
